Search Videos and More
UTSW Researchers Discover New Drug Target for Inflammatory Bowel Disease
A set of interacting molecules in immune cells of the gut is responsible for preventing the inflammation seen in inflammatory bowel diseases (IBD), UT Southwestern researchers report in a new study. The findings, published in Cell Reports, suggest a new drug target for treating IBD and related conditions.Behind the Scenes: SSO Robotic Surgery Pre-Meeting
Step behind the scenes at UT Southwestern’s Robotic Surgery Symposium at the Society of Surgical Oncology 2022 meeting in Dallas, TexasResearch into Cachexia Seeks Treatment for Muscle-wasting Condition
Dr. Infante’s research group has identified several influential molecules that are secreted from tumors or their associated inflammation.Happiness Might Protect You from Gastrointestinal Distress!
Serotonin, a chemical known for its role in producing feelings of well-being and happiness in the brain, can reduce the ability of some intestinal pathogens to cause deadly infections, new research by UT Southwestern scientists suggests.Stomach Issues, History of Substance Abuse Found in Teen Vaping Study
A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse, UT Southwestern researchers found in one of the first clinical reviews of its kind.Fighting Inflammatory Bowel Disease at Its Source
New findings on mechanism for intestinal inflammation could offer new targets for treating ulcerative colitis, Crohn’s disease, and other conditions